Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction.
Thadani
Udho
U
Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, Oklahoma 73104, USA. udho-thadani@ouhsc.edu
D000787:Angina Pectoris; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D014292:Trimetazidine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D014665:Vasodilator Agents / Q000008:administration & dosage*
D003692:Delayed-Action Preparations; D014665:Vasodilator Agents; D014292:Trimetazidine